Granules India is currently trading at Rs. 116.50, up by 1.50 points or 1.30% from its previous closing of Rs. 115.00 on the BSE.
The scrip opened at Rs. 117.00 and has touched a high and low of Rs. 117.85 and Rs. 115.45 respectively. So far 124574 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 151.15 on 14-Jul-2016 and a 52 week low of Rs. 91.45 on 09-Nov-2016.
Last one week high and low of the scrip stood at Rs. 117.85 and Rs. 110.40 respectively. The current market cap of the company is Rs. 2577.20 crore.
The promoters holding in the company stood at 51.88%, while institutions and non-institutions held 7.24% and 40.88% respectively.
Granules India has received an approval for further investment of $20 million in Granules Pharmaceuticals Inc., a wholly owned subsidiary of the company. The board of directors at its meeting held on January 28, 2017 has approved for the same.
Granules India is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs).
